Home » Norwood Receives TGA for Laser Vision Correction Technology
Norwood Receives TGA for Laser Vision Correction Technology
April 8, 2005
Richard Walmsley, Chief Executive Officer of Norwood Devices, a division of
medical technologies group Norwood Abbey, announced the company had received
Therapeutic Goods Administration (TGA) approval for its Centurion SES Epikeratome
the key component of Epi-LASIK technology, the next generation of vision
correction surgery. TGA approval in Australia follows FDA and European CE Mark
approvals in 2004.
Business
Wire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct